Back
Protagonist Therapeutics Stock Predictions
Sponsored
PTGX
Sponsored
Gold Set to Skyrocket as Fed Slashes Rates
Click here for the details on this incredible opportunity.
Buy
51
PTGX
Protagonist Therapeutics
Last Price:
46.48
Seasonality Move:
13.32%
7 Day Trial
ALL ACCESS PASS
$
7
The truth about AI stocks (must see)
Learn the names of all 10 stocks here. FREE.Protagonist Therapeutics Stock Forecast
- Over the next 52 weeks, Protagonist Therapeutics has on average historically risen by 38.3% based on the past 8 years of stock performance.
- Protagonist Therapeutics has risen higher in 5 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%
-
Is Protagonist Therapeutics Stock Undervalued?
The current Protagonist Therapeutics [PTGX] share price is $46.44. The Score for PTGX is 51, which is 2% above its historic median score of 50, and infers lower risk than normal. - PTGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Protagonist Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Protagonist Therapeutics has on average historically risen by 38.3% based on the past 8 years of stock performance.
Protagonist Therapeutics Stock Rating
Buy
51
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics overpriced?
- Protagonist Therapeutics has risen higher in 5 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%
Protagonist Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
protagonist-inc.com
52-Week Data
52-Week High:
48.32
52-Week Low:
13.72
Prediction Charts
Market Cap:
2.74B
Price in USD:
46.44
Volume:
310.09K
Beta:
2.10
Technical Analysis
SMA50:
43.96
SMA100:
39.42
SMA200:
33.50
52-Wk Change:
222.05%
Stock Predictions
-
Is Protagonist Therapeutics stock public?
Yes, Protagonist Therapeutics is a publicly traded company. -
What is the Protagonist Therapeutics stock quote today?
The Protagonist Therapeutics stock price is 46.44 USD today. -
How to buy Protagonist Therapeutics stock online?
You can buy Protagonist Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-2 | 44.15 | 44.98 | 45.06 | 43.56 |
Oct-3 | 44.91 | 44.34 | 45.24 | 43.93 |
Oct-4 | 44.63 | 44.37 | 45.24 | 44.16 |
Oct-7 | 44.18 | 43.75 | 44.24 | 42.78 |
Oct-8 | 44.15 | 43.96 | 44.67 | 43.92 |
Oct-9 | 43.95 | 44.18 | 44.61 | 43.33 |
Oct-10 | 43.64 | 43.59 | 44.53 | 43.18 |
Oct-11 | 43.56 | 45.08 | 45.34 | 43.56 |
Oct-14 | 44.96 | 46.35 | 46.90 | 44.77 |
Oct-15 | 46.62 | 47.64 | 48.32 | 46.59 |
Oct-16 | 47.78 | 46.99 | 48.02 | 46.77 |
Oct-18 | 47.20 | 46.97 | 47.53 | 46.69 |
Oct-21 | 46.80 | 45.96 | 47.03 | 45.51 |
Oct-22 | 45.38 | 46.44 | 46.53 | 45.33 |
Protagonist Therapeutics Earnings
Protagonist Therapeutics Earnings Report: Per Share Protagonist Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Protagonist Therapeutics Forecast Revenue Growth
Protagonist Therapeutics Stock Analysis: Historical quarterly revenues per share for Protagonist Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.50 per share, and a decrease next year of $2.97 per share.
* Protagonist Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.